MedPath

A comparative study of intubating conditions and hemodynamic parameters during general anesthesia using rocuronium and vecuronium in patients undergoing laparoscopic surgeries. A prospective randomized double blind study

Phase 4
Not yet recruiting
Conditions
Medical and Surgical,
Registration Number
CTRI/2023/06/053643
Lead Sponsor
SDM COLLEGE OF MEDICAL SCIENCES AND HOSPITAL
Brief Summary

THIS IS A RANDOMISED DOUBLE BLINDED STUDY WHERE WE ARE COMPARING THE HEMODYNAMIC PARAMETERS AND INTUBATING CONDITIONS USING ROCURONIUM AND VECURONIUM DURING GENERAL ANAESTHESIA IN PATIENTS UNDERGOING LAPAROSCOPIC SURGERIES.

HERE WE WILL BE USING EQUIPOTENT DOSES OF BOTH THE MUSCLE RELAXANT, THAT IS THE 2 TIMES ED 95 OF BOTH THE DRUGS.

AS PER THE EXPECTED OUTCOME ROCURONIUM WILL PROVIDE MORE STABLE HEMODYNAMIC CONDITIONS AND BETTER INTUBATING CONDITIONS WHEN COMPARED TO VECURONIUM.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria
  • ANTICIPATED DIFFICULT AIRWAY.
  • ASA 3 AND ABOVE.
  • ANTICIPATED MAJOR BLOOD LOSS.
  • MAJOR SYSTEMIC DISEASES.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
inj. Rocuronium 0.6mg/kg provides better intubating conditions and maintains stable hemodynamic parameters during general anesthesia.baseline
Secondary Outcome Measures
NameTimeMethod
To assess the adverse drug reaction caused by either of the the muscle relaxant used and also the time interval required between the intubating dose and 1st top up.baseline

Trial Locations

Locations (1)

SDM COLLEGE OF MEDICAL SCIENCES AND HOSPITAL

🇮🇳

Dharwad, KARNATAKA, India

SDM COLLEGE OF MEDICAL SCIENCES AND HOSPITAL
🇮🇳Dharwad, KARNATAKA, India
Dr GUBBI VISHWANATH SAI ASHRAY
Principal investigator
8147161773
ashraysai.98@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.